Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 350 participants.
Also called NCT07521475
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 350 participants
- Registry
-
NCT07521475
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT07521475. Randomized; no masking; primary purpose treatment. Start 2026-04-30 (actual); primary completion 2026-12-24 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
- Acronym
- EVOLVE
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Device)
- Device: Omnipod M System with study CGM
- Intervention (Device)
- Standard Therapy plus study CGM
- Lead sponsor
- Insulet Corporation
- Collaborator
- Jaeb Center for Health Research
Record details
- Record id
cardio:ct-nct07521475- Content hash
4f8d3143297fd44c31fb46bb30956c2a4099b8a2968a27a0ecc57c42ad9a2fe1